Role of a type IV-like secretion system of Streptococcus suis 2 in the development of streptococcal toxic shock syndrome

Journal of Infectious Diseases

Volumn 204, Issue 2, 2011, Pages 274-281

  Zhao, Yan ^a   Liu, Gaoke ^a   Li, Shu ^a   Wang, Min ^a   Song, Jie ^a   Wang, Jing ^a   Tang, Jiaqi ^b   Li, Ming ^a   Hu, Fuquan ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b Research Institute for Medicine of Nanjing Command   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BIOINFORMATICS; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ACTIVITY; IMMUNE RESPONSE; MODULATION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; STREPTOCOCCUS SUIS; SURVIVAL RATE; TOXIC SHOCK SYNDROME; TYPE IV SECRETION SYSTEM;

ANIMALS; BACTERIAL PROTEINS; CHINA; CYTOKINES; DISEASE MODELS, ANIMAL; GENE KNOCKOUT TECHNIQUES; GENOMIC ISLANDS; HISTOCYTOCHEMISTRY; HUMANS; LIVER; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED BALB C; SHOCK, SEPTIC; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS SUIS; SURVIVAL ANALYSIS; VIRULENCE;

EID: 79958715784     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir261     Document Type: Article

References (36)

1. Staats JJ, Feder I, Okwumabua O, Chengappa MM. Streptococcus suis: past and present. Vet Res Commun 1997; 21:381-407. (Pubitemid 27348987)
2. Lun ZR, Wang QP, Chen XG, Li AX, Zhu XQ. Streptococcus suis: an emerging zoonotic pathogen. Lancet Infect Dis 2007; 7:201-9.
3. Gottschalk M, Xu J, Calzas C, Segura M. Streptococcus suis: a new emerging or an old neglected zoonotic pathogen? Future Microbiol 2010; 5:371-91.
4. Tang J, Wang C, Feng Y, et al. Streptococcal toxic shock syndrome caused by Streptococcus suis serotype 2. PLoS Med 2006; 3:e151.
5. Normile D. Infectious diseases. WHOprobes deadliness of China's pig-borne disease. Science 2005; 309:1308-9.
6. Sriskandan S, Slater JD. Invasive disease and toxic shock due to zoonotic Streptococcus suis: an emerging infection in the East? PLoS Med 2006; 3:e187.
7. Brown EJ. The molecular basis of streptococcal toxic shock syndrome. N Engl J Med 2004; 350:2093-4. (Pubitemid 38596563)
8. Stevens DL, Tanner MH, Winship J, et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989; 321:1-7. (Pubitemid 19170377)
9. Lindsay JA, Ruzin A, Ross HF, Kurepina N, Novick RP. The gene for toxic shock toxin is carried by a family of mobile pathogenicity islands in Staphylococcus aureus. Mol Microbiol 1998; 29:527-43. (Pubitemid 28330786)
10. Wood TF, Potter MA, Jonasson O. Streptococcal toxic shock-like syndrome. The importance of surgical intervention. Ann Surg 1993; 217:109-14.
11. Herwald H, Cramer H, Morgelin M, et al. M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage. Cell 2004; 116:367-79. (Pubitemid 38366314)
12. dys). FEMS Immunol Med Microbiol 2002; 34:159-67.
13. Chen C, Tang J, Dong W, et al. A glimpse of streptococcal toxic shock syndrome from comparative genomics of S. suis 2 Chinese isolates. PLoS One 2007; 2:e315.
14. Li M, Wang C, Feng Y, et al. SalK/SalR, a two-component signal transduction system, is essential for full virulence of highly invasive Streptococcus suis serotype 2. PLoS One 2008; 3:e2080.
15. Juhas M, Crook DW, Hood DW. Type IV secretion systems: tools of bacterial horizontal gene transfer and virulence. Cell Microbiol 2008; 10:2377-86.
16. Saito H, Yamaoka Y, Ishizone S, et al. Roles of virD4 and cagG genes in the cag pathogenicity island of Helicobacter pylori using a Mongolian gerbil model. Gut 2005; 54:584-90. (Pubitemid 40559238)
17. Schmid MC, Schulein R, Dehio M, Denecker G, Carena I, Dehio C. The VirB type IV secretion system of Bartonella henselae mediates invasion, proinflammatory activation and antiapoptotic protection of endothelial cells. Mol Microbiol 2004; 52:81-92. (Pubitemid 38519623)
18. Takamatsu R, Teruya H, Takeshima E, et al. Molecular characterization of Legionella pneumophila-induced interleukin-8 expression in T cells. BMC Microbiol 2010; 10:1.
19. Ye C, Zheng H, Zhang J, et al. Clinical, experimental, and genomic differences between intermediately pathogenic, highly pathogenic, and epidemic Streptococcus suis. J Infect Dis 2009; 199:97-107.
20. Ye C, Zhu X, Jing H, et al. Streptococcus suis sequence type 7 outbreak, Sichuan, China. Emerg Infect Dis 2006; 12:1203-8.
21. Chesney PJ. Toxic-shock syndrome: a commentary and review of the characteristics of Staphylococcus aureus strains. Infection 1983; 11:181-8. (Pubitemid 13039044)
22. Christie PJ, Atmakuri K, Krishnamoorthy V, Jakubowski S, Cascales E. Biogenesis, architecture, and function of bacterial type IV secretion systems. Annu Rev Microbiol 2005; 59:451-85. (Pubitemid 41507439)
23. Celli J, Salcedo SP, Gorvel JP. Brucella coopts the small GTPase Sar1 for intracellular replication. Proc Natl Acad Sci U S A 2005; 102:1673-8. (Pubitemid 40209226)
24. Celli J, de Chastellier C, Franchini DM, Pizarro-Cerda J, Moreno E, Gorvel JP. Brucella evades macrophage killing via VirB-dependent sustained interactions with the endoplasmic reticulum. J Exp Med 2003; 198:545-56. (Pubitemid 37040389)
25. Backert S, Schwarz T, Miehlke S, et al. Functional analysis of the cag pathogenicity island in Helicobacter pylori isolates from patients with gastritis, peptic ulcer, and gastric cancer. Infect Immun 2004; 72:1043-56. (Pubitemid 38166687)
26. Selbach M, Moese S, Meyer TF, Backert S. Functional analysis of the Helicobacter pylori cag pathogenicity island reveals both VirD4-CagA-dependent and VirD4-CagA-independent mechanisms. Infect Immun 2002; 70:665-71. (Pubitemid 34083826)
27. Backert S, Moese S, Selbach M, Brinkmann V, Meyer TF. Phosphorylation of tyrosine 972 of the Helicobacter pylori CagA protein is essential for induction of a scattering phenotype in gastric epithelial cells. Mol Microbiol 2001; 42:631-44. (Pubitemid 33064475)
28. Ren T, Zamboni DS, Roy CR, Dietrich WF, Vance RE. Flagellin-deficient Legionella mutants evade caspase-1- and Naip5-mediated macrophage immunity. PLoS Pathog 2006; 2:e18.
29. Verhoef J, Mattsson E. The role of cytokines in gram-positive bacterial shock. Trends Microbiol 1995; 3:136-40.
30. Saukkonen K, Sande S, Cioffe C, et al. The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis. J Exp Med 1990; 171:439-48. (Pubitemid 20059038)
31. Norrby-Teglund A. Correlation between serum TNFa and IL6 levels and Severity of group A streptococcal infections. Scand J Infect Dis 1995; 27:125-130.
32. Dominguez-Punaro MC, Segura M, Plante MM, Lacouture S, Rivest S, Gottschalk M. Streptococcus suis serotype 2, an important swine and human pathogen, induces strong systemic and cerebral inflammatory responses in a mouse model of infection. J Immunol 2007; 179:1842-54.
33. Dofferhoff AS, Vellenga E, Limburg PC, van Zanten A, Mulder PO, Weits J. Tumour necrosis factor (cachectin) and other cytokines in septic shock: a review of the literature. Neth J Med 1991; 39:45-62.
34. Song M, Kellum JA. Interleukin-6. Crit Care Med 2005; 33:S463-5.
35. Mancuso G, Cusumano V, Genovese F, Gambuzza M, Beninati C, Teti G. Role of interleukin 12 in experimental neonatal sepsis caused by group B streptococci. Infect Immun 1997; 65:3731-5. (Pubitemid 27398133)
36. Gu H, Zhu H, Lu C. Use of in vivo-induced antigen technology (IVIAT) for the identification of Streptococcus suis serotype 2 in vivo-induced bacterial protein antigens. BMC Microbiol 2009; 9:201.